Failure of Nimodipine to Reverse Acute Experimental Spinal Cord Injury
- 1 January 1985
- journal article
- research article
- Published by Mary Ann Liebert Inc in Central Nervous System Trauma
- Vol. 2 (1) , 9-16
- https://doi.org/10.1089/cns.1985.2.9
Abstract
The calcium-channel blocking agent, nimodipine, was administered to cats for 5 days after acute experimental SCI. Six weeks after injury, no significant differences in neurologic recovery or white matter tissue preservation at the injury site were found between treated and control animals. Key Words: Spinal cord injury–Nimodipine–Calcium-channel antagonist.Keywords
This publication has 30 references indexed in Scilit:
- Therapeutic trial of hypercarbia and hypocarbia in acute experimental spinal cord injuryJournal of Neurosurgery, 1984
- Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemiaJournal of Neurosurgery, 1984
- The role of ethanol in diluents of drugs that protect mice from hypoxia.Stroke, 1983
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery.Stroke, 1983
- The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia.Stroke, 1982
- Prevention of symptomatic vasospasm by topically applied NimodipineActa Neurochirurgica, 1982
- Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular actionActa Neurochirurgica, 1982
- Effect of the Calcium Antagonist, Nimodipine, on Cerebral Blood Flow and Metabolism in the PrimateJournal of Cerebral Blood Flow & Metabolism, 1981
- Effect of naloxone on posttraumatic ischemia in experimental spinal contusionJournal of Neurosurgery, 1981